These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 17108082)

  • 1. Enhanced anxiety and stress-induced corticosterone release are associated with increased Crh expression in a mouse model of Rett syndrome.
    McGill BE; Bundle SF; Yaylaoglu MB; Carson JP; Thaller C; Zoghbi HY
    Proc Natl Acad Sci U S A; 2006 Nov; 103(48):18267-72. PubMed ID: 17108082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Affective dysfunction in a mouse model of Rett syndrome: Therapeutic effects of environmental stimulation and physical activity.
    Kondo MA; Gray LJ; Pelka GJ; Leang SK; Christodoulou J; Tam PP; Hannan AJ
    Dev Neurobiol; 2016 Feb; 76(2):209-24. PubMed ID: 26019053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MeCP2 binds to non-CG methylated DNA as neurons mature, influencing transcription and the timing of onset for Rett syndrome.
    Chen L; Chen K; Lavery LA; Baker SA; Shaw CA; Li W; Zoghbi HY
    Proc Natl Acad Sci U S A; 2015 Apr; 112(17):5509-14. PubMed ID: 25870282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methyl CpG-binding protein 2 (a mutation of which causes Rett syndrome) directly regulates insulin-like growth factor binding protein 3 in mouse and human brains.
    Itoh M; Ide S; Takashima S; Kudo S; Nomura Y; Segawa M; Kubota T; Mori H; Tanaka S; Horie H; Tanabe Y; Goto Y
    J Neuropathol Exp Neurol; 2007 Feb; 66(2):117-23. PubMed ID: 17278996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective preservation of cholinergic MeCP2 rescues specific Rett-syndrome-like phenotypes in MeCP2
    Zhou H; Wu W; Zhang Y; He H; Yuan Z; Zhu Z; Zhao Z
    Behav Brain Res; 2017 Mar; 322(Pt A):51-59. PubMed ID: 28093257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neonatal exposure to low dose corticosterone persistently modulates hippocampal mineralocorticoid receptor expression and improves locomotor/exploratory behaviour in a mouse model of Rett syndrome.
    De Filippis B; Ricceri L; Fuso A; Laviola G
    Neuropharmacology; 2013 May; 68():174-83. PubMed ID: 22709945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-specific expression of wild-type MeCP2 in mouse models of Rett syndrome yields insight about pathogenesis.
    Alvarez-Saavedra M; Sáez MA; Kang D; Zoghbi HY; Young JI
    Hum Mol Genet; 2007 Oct; 16(19):2315-25. PubMed ID: 17635839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the possible link between MeCP2 and oxidative stress in Rett syndrome.
    Filosa S; Pecorelli A; D'Esposito M; Valacchi G; Hajek J
    Free Radic Biol Med; 2015 Nov; 88(Pt A):81-90. PubMed ID: 25960047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FXYD1 is an MeCP2 target gene overexpressed in the brains of Rett syndrome patients and Mecp2-null mice.
    Deng V; Matagne V; Banine F; Frerking M; Ohliger P; Budden S; Pevsner J; Dissen GA; Sherman LS; Ojeda SR
    Hum Mol Genet; 2007 Mar; 16(6):640-50. PubMed ID: 17309881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rett syndrome like phenotypes in the R255X Mecp2 mutant mouse are rescued by MECP2 transgene.
    Pitcher MR; Herrera JA; Buffington SA; Kochukov MY; Merritt JK; Fisher AR; Schanen NC; Costa-Mattioli M; Neul JL
    Hum Mol Genet; 2015 May; 24(9):2662-72. PubMed ID: 25634563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CpG methylation and the methyl CpG binding protein 2 (MeCP2) are required for restraining corticotropin releasing hormone (CRH) gene expression.
    Bhave SA; Uht RM
    Mol Cell Endocrinol; 2017 Oct; 454():158-164. PubMed ID: 28655627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MeCP2 dysfunction in Rett syndrome and related disorders.
    Moretti P; Zoghbi HY
    Curr Opin Genet Dev; 2006 Jun; 16(3):276-81. PubMed ID: 16647848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation mechanism and research progress of MeCP2 in Rett syndrome.
    Yang W; Pan H
    Yi Chuan; 2014 Jul; 36(7):625-30. PubMed ID: 25076025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disruption of DNA-methylation-dependent long gene repression in Rett syndrome.
    Gabel HW; Kinde B; Stroud H; Gilbert CS; Harmin DA; Kastan NR; Hemberg M; Ebert DH; Greenberg ME
    Nature; 2015 Jun; 522(7554):89-93. PubMed ID: 25762136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MeCP2-mediated alterations of striatal features accompany psychomotor deficits in a mouse model of Rett syndrome.
    Kao FC; Su SH; Carlson GC; Liao W
    Brain Struct Funct; 2015 Jan; 220(1):419-34. PubMed ID: 24218106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crh and Oprm1 mediate anxiety-related behavior and social approach in a mouse model of MECP2 duplication syndrome.
    Samaco RC; Mandel-Brehm C; McGraw CM; Shaw CA; McGill BE; Zoghbi HY
    Nat Genet; 2012 Jan; 44(2):206-11. PubMed ID: 22231481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral and anatomical abnormalities in Mecp2 mutant mice: a model for Rett syndrome.
    Stearns NA; Schaevitz LR; Bowling H; Nag N; Berger UV; Berger-Sweeney J
    Neuroscience; 2007 May; 146(3):907-21. PubMed ID: 17383101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MeCP2 R168X male and female mutant mice exhibit Rett-like behavioral deficits.
    Schaevitz LR; Gómez NB; Zhen DP; Berger-Sweeney JE
    Genes Brain Behav; 2013 Oct; 12(7):732-40. PubMed ID: 24283265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective preservation of MeCP2 in catecholaminergic cells is sufficient to improve the behavioral phenotype of male and female Mecp2-deficient mice.
    Lang M; Wither RG; Brotchie JM; Wu C; Zhang L; Eubanks JH
    Hum Mol Genet; 2013 Jan; 22(2):358-71. PubMed ID: 23077217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postnatal loss of methyl-CpG binding protein 2 in the forebrain is sufficient to mediate behavioral aspects of Rett syndrome in mice.
    Gemelli T; Berton O; Nelson ED; Perrotti LI; Jaenisch R; Monteggia LM
    Biol Psychiatry; 2006 Mar; 59(5):468-76. PubMed ID: 16199017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.